Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,336,315
-
Share change
-
+122,282
-
Total reported value
-
$262,774,059
-
Price per share
-
$60.60
-
Number of holders
-
104
-
Value change
-
+$7,514,836
-
Number of buys
-
48
-
Number of sells
-
46
Institutional Holders of BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) as of Q4 2018
As of 31 Dec 2018,
BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,336,315 shares.
The largest 10 holders included
BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, Vanguard Group Inc, RICE HALL JAMES & ASSOCIATES, LLC, Stonepine Capital Management, LLC, GOLDMAN SACHS GROUP INC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, and Elk Creek Partners, LLC.
This page lists
104
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.